Erlotinib Hydrochloride

Product NDC
42292-051
11-digit product format
422920051
Labeler code
42292
Product ID
42292-051_b4dc994e-d507-2fc0-e053-2a95a90ae131
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
erlotinib hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Mylan Institutional Inc.
Application
ANDA091002
Marketing category
ANDA
Marketing start
2019-05-28
Marketing end
2021-01-31
Substance
ERLOTINIB
Active strength
25 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42292-051-01EA - Each42292-051f96d7e0e-8c94-4404-9c5d-3c5104587f4912019-06-19
42292-051-05EA - Each42292-0511defce63-bea9-4240-b978-68f1637beb3912019-06-19